Search

everythingexperts & clinicslearnresearchcommunity

for

Search:↓

A topical treatment safely and effectively reduced acne by causing targeted cell death in sebaceous glands without side effects.

Cyclosporin A, a drug, reduces TGF-β2 expression in skin cells, potentially causing excessive hair growth through a process involving the calcineurin/NFAT pathway.

PDCD4 protein levels, affected by genetics and breastfeeding, may predict breast cancer treatment response.

Necrobiosis lipoidica may need new criteria for accurate diagnosis due to similarities with another condition.

Fibroblast Growth Factor-9 helps repair heart damage after a heart attack by creating new blood vessels, especially in diabetics.

Mice genetically modified to produce more Del1 protein had faster hair regrowth.

CD34⁺ cells help heal damaged limbs by promoting blood vessel growth.

The antibody created from BCC tissues reacts similarly to both BCC and hair follicles, suggesting BCC may come from hair follicle cells.

Probe detects finasteride with high selectivity and low detection limit.

CD8+ T cells play a key role in graft-versus-host disease in certain mice models.

Tissue environment greatly affects the unique epigenetic makeup of regulatory T cells, which could impact autoimmune disease treatment.

Alopecia areata patients have lower SOX9 and CD34 levels, affecting hair growth.

Certain immune cells in atopic dermatitis skin could be targeted for treatment.

Vδ1+ T-cells in the skin contribute to hair loss in alopecia areata and could be targeted for treatment.

DMBT1 and galectin-3 may help suppress epithelial skin cancer.

AL136131.3 slows hair growth by affecting energy processes in hair loss.

Amotosalen-treated donor T-cells can prevent late CMV infection after bone marrow transplants.

Vitisin A reduces triglycerides better than Cyanidin-3-O-glucoside.

The formula YH0618 can reduce the harmful side effects of the chemotherapy drug Doxorubicin and protect healthy cells.

UC.145 may be a new biomarker for predicting gastric cancer.

Bexxar treatment led to a high response rate in patients with advanced-stage, treatment-resistant follicular lymphoma.

AP-1 and TGFß work together to drive resistance in basal cell carcinoma, suggesting new treatment options.

Scientists made a carbon-14 labeled version of a drug with a 48% yield and over 99% purity.

Discoid lupus erythematosus involves immune activation and fibrosis around hair follicles, with shared pathways across humans, dogs, and mice, suggesting potential treatments for both humans and animals.

Using 5-α-reductase inhibitors before treatment improves outcomes for patients with metastatic renal cell carcinoma.

CK 19 expression is higher in more severe skin cancers.

Combining specific nanoparticles with immune therapy significantly improves cancer treatment.

Doxil showed some effectiveness against advanced prostate cancer but caused severe side effects at higher doses.